ATE515259T1 - Pharmazeutische zusammensetzung mit eszopiclon - Google Patents

Pharmazeutische zusammensetzung mit eszopiclon

Info

Publication number
ATE515259T1
ATE515259T1 AT07109085T AT07109085T ATE515259T1 AT E515259 T1 ATE515259 T1 AT E515259T1 AT 07109085 T AT07109085 T AT 07109085T AT 07109085 T AT07109085 T AT 07109085T AT E515259 T1 ATE515259 T1 AT E515259T1
Authority
AT
Austria
Prior art keywords
eszopiclone
pharmaceutical composition
composition containing
particle size
relates
Prior art date
Application number
AT07109085T
Other languages
English (en)
Inventor
Zdenka Jerala-Strukelj
Igor Legen
Sebastjan Reven
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE515259T1 publication Critical patent/ATE515259T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT07109085T 2007-05-29 2007-05-29 Pharmazeutische zusammensetzung mit eszopiclon ATE515259T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07109085A EP1997482B1 (de) 2007-05-29 2007-05-29 Pharmazeutische Zusammensetzung mit Eszopiclon

Publications (1)

Publication Number Publication Date
ATE515259T1 true ATE515259T1 (de) 2011-07-15

Family

ID=38224070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07109085T ATE515259T1 (de) 2007-05-29 2007-05-29 Pharmazeutische zusammensetzung mit eszopiclon

Country Status (4)

Country Link
US (1) US20080299193A1 (de)
EP (1) EP1997482B1 (de)
AT (1) ATE515259T1 (de)
SA (1) SA08290275B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090269409A1 (en) * 2008-04-24 2009-10-29 Mukesh Kumar Garg Pharmaceutical compositions comprising eszopiclone
EP2345654A1 (de) 2010-01-05 2011-07-20 LEK Pharmaceuticals d.d. Eszopiclon-Teilchen und Verfahren zu deren Herstellung
CN104706615A (zh) * 2014-05-07 2015-06-17 迪沙药业集团有限公司 一种药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107854T1 (de) * 1988-09-30 1994-07-15 Rhone Poulenc Rorer Ltd Pharmazeutisches granulat.
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
KR20070007276A (ko) * 2003-12-29 2007-01-15 제이슨 맥데빗 재발성 의학적 증상을 치료하기 위한 조성물 및 방법
EP1904046A4 (de) * 2005-07-06 2008-10-01 Sepracor Inc Kombinationen von eszopiclon und o-desmethylvenlafaxin und verfahren zur behandlung der menopause und von stimmungsschwankungen; angstzuständen und kognitiven störungen
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
BRPI0621028A2 (pt) * 2006-01-17 2011-11-29 Glenmark Pharmaceuticals Ltd processo para a preparação de um derivado de 5h-pirrolo[3,4-b]pirazina oticamente ativo

Also Published As

Publication number Publication date
EP1997482B1 (de) 2011-07-06
US20080299193A1 (en) 2008-12-04
EP1997482A1 (de) 2008-12-03
SA08290275B1 (ar) 2013-04-20

Similar Documents

Publication Publication Date Title
DE602007010797D1 (de) Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
EP2096958A4 (de) Vielseitige dreiteilige puderdose mit entkoppelter bewegung
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
EP3939617C0 (de) Verbindungen zur herstellung von konjugaten mit einer intrazellulär spaltbaren bindung
ATE548423T1 (de) Sauerstoffabsorbierende kunststoffzusammensetzungen
BRPI0810646A2 (pt) " compostos farmacêuticos ".
CL2008000944S1 (es) Contenedor transparente.
DE602008004217D1 (de) Pharmazeutische zusammensetzung
IL186692A0 (en) Novel materials used for emitting light
BRPI0913806A2 (pt) "composição"
EP2167602A4 (de) Zusammensetzungen mit difluormethan
HUE044237T2 (hu) Kortexolon-17-alfa-propionátot tartalmazó gyógyszerészeti kompozíciók
EP2227084A4 (de) Viruzide zusammensetzung
BRPI0911051A2 (pt) composição de resina termoplástica.
EP2172196A4 (de) Coenzym q10 enthaltende zusammensetzung
EP2149563A4 (de) Neue pyrimidinverbindung mit dibenzylaminstruktur und die verbindung enthaltende medizin
CL2008000942S1 (es) Contenedor transparente.
CL2008000943S1 (es) Contenedor transparente.
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
FI20090127L (fi) Polymeerikoostumus, joka soveltuu pastöroitavien säilytysastioiden valmistamiseen
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
GT200700074A (es) Fungicidas
BRPI0822782A2 (pt) composição farmacêutica que compreende rosuvastatina
ATE533477T1 (de) Pharmazeutische zusammensetzungen enthaltend irbesartan
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties